Skip to content

Screening for prevention of cardiovascular diseases after pregnancy in the general practice

CVRM for the PRevention of cardiOvascular diseAse after pregnanCy: a pilot study (PROACTIVE) - CVRM for the PRevention of cardiOvascular diseAse after pregnanCy:a Targeted InterVEntion(PROACTIVE)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON61177
Enrollment
50
Registered
2026-05-21
Start date
2026-06-25
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertensive disorder of pregnancy, pre-eclampsia, HELLP, gestational diabetes High blood pressure in pregnancy, pre-eclampsia diabetes in pregnancy

Interventions

The implementation of a proactive cardiometabolic risk management (CVRM) program for women who have experienced hypertensive disorders of pregnancy or gestational diabetes.

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this pilot study, a health care professional must meet the following criteria: - Practicing General practitioner (GP) or Practice nurse (POH) in the chosen general practice affiliated with ELAN  In order to be eligible to participate in this study, a patient, must meet all of the following criteria: - All women with a history of hypertensive disorder or pregnancy (HDP) and/or gestational diabetes (GD) up to 5 years prior to study start are eligible for inclusion

Exclusion criteria

Exclusion criteria: A potential patient who meets any of the following criteria will be excluded from participation in this study: - Under 18 years of age - Already included in another Integrated Care program - Women who are currently pregnant - Women who have opt-out of access to routine care data (ELAN)

Design outcomes

Primary

MeasureTime frame
The primary endpoints are the acceptability, appropriateness and feasibility of the CVRM program.

Secondary

MeasureTime frame
The secondary endpoints are rates of recruitments, adoption of the program, fidelity of implementation strategies, possible negative outcomes of screening, lifestyle changes, and the incidence of cardiometabolic risk factors found when proactively screening.

Countries

Netherlands

Contacts

Public ContactS. van Smoorenburg

Leids Universitair Medisch Centrum

proactive@lumc.nl071 526 84 44

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jul 23, 2026